Northwire Canada EditionWednesday, July 15, 2026
Northwire
SGQ 0.400 +5.3% GMX 1.87 −1.6% ALM 0.310 +0.0% WCU 0.010 +0.0% NTH 0.155 −6.1% GGM 0.035 +0.0% FG 0.035 +0.0% EFR 17.76 −4.5% IVN 10.51 −2.5% MASS 0.090 +0.0% LIF 26.57 −2.3% CPAU 0.155 +0.0% PTX 0.105 −4.5% VENT 0.160 +0.0% ANK 0.278 −4.3% ODV 3.38 +0.3% SGQ 0.400 +5.3% GMX 1.87 −1.6% ALM 0.310 +0.0% WCU 0.010 +0.0% NTH 0.155 −6.1% GGM 0.035 +0.0% FG 0.035 +0.0% EFR 17.76 −4.5% IVN 10.51 −2.5% MASS 0.090 +0.0% LIF 26.57 −2.3% CPAU 0.155 +0.0% PTX 0.105 −4.5% VENT 0.160 +0.0% ANK 0.278 −4.3% ODV 3.38 +0.3%
Financings

Orogen Royalties Announces Non-Brokered Private Placement of up to $10 Million

OGN · Price

Executive Summary

  • Orogen Royalties Inc. announced a non‑brokered private placement to raise up to $10 million by issuing up to 2,890,274 common shares at $3.46 per share.
  • Proceeds will be used for generative exploration initiatives, potential royalty acquisitions, and to bolster working capital for growth.
  • The placement includes a 5% cash finder's fee on shares sold through introduced investors, a four‑month hold period on the issued shares, and may involve participation by directors/officers as a related‑party transaction exempt from certain MI 61‑101 approvals.

Key Details

  • Offering Size: Up to $10,000,000 total gross proceeds.
  • Shares Offered: Up to 2,890,274 common shares.
  • Price per Share: $3.46 CAD.
  • Use of Proceeds:
  • Development of generative exploration projects.
  • Execution of potential royalty acquisitions.
  • Strengthening working capital for ongoing growth strategy.
  • Related‑Party Participation: Directors and officers may purchase shares; transaction exempt from formal valuation/minority shareholder approval because it does not exceed 25 % of market cap.
  • Finder’s Fee: 5 % cash fee on shares sold to investors introduced by finders, subject to TSX Venture Exchange approval.
  • Hold Period: All issued shares subject to a four‑month hold period under Canadian securities laws and applicable foreign hold periods from closing date.
  • Closing Timeline: Anticipated within approximately 3–4 weeks of the announcement, contingent on regulatory and exchange approvals.
  • Regulatory Notices: No offer or solicitation in the United States; shares not registered under U.S. securities laws.

Notable Quotes

  • “The private placement will provide us with the capital needed to advance our exploration programs and pursue strategic royalty acquisitions, positioning Orogen for continued growth.” – Paddy Nicol, President & CEO

All forward‑looking statements are subject to risks and uncertainties that could cause actual results to differ materially.

Read the original news release →

More from Orogen Royalties Inc.